← Open Payments lookup

ANURADHA THIRUMALAI: Open Payments

NPI 1306217534 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,759 in 241 payments from 36 companies in 2025. Trend: 2023 $3,569 · 2024 $5,449 · 2025 $5,759

Food & beverage: $5,689Education: $70
CompanyPaymentsAmount
ABBVIE INC.37$665
Biogen, Inc.22$584
UCB, Inc.16$550
ARGENX US, INC.11$401
Genentech USA, Inc.12$395
EMD Serono, Inc.11$334
Celgene Corporation19$276
Lilly USA, LLC9$239
Otsuka America Pharmaceutical, Inc.12$234
Novartis Pharmaceuticals Corporation21$217

Products named: QULIPTA, VYVGART HYTRULO, REXULTI, TYSABRI, ZEPOSIA, Nayzilam, Ocrevus Zunovo, Briviact.

Industry payments across NV — which companies pay providers there.